EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus

Shanwen Chen, Yanxun Han, Yuchen Liu, Jiaxin Li, Qiling Shen, Yichen Li, Chunhui Tian, Yehai Liu

Head and Neck Diseases Conflux · 2025

DOI: 10.71321/5nx25d85 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head and Neck Diseases Conflux, 2025. Verfasst von Shanwen Chen und 7 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in combination with retroauricular glucocorticoid injection for the treatment of chronic tinnitus.

Methods

This prospective, single-arm study enrolled a total of 34 patients with chronic tinnitus. All participants received combined therapy consisting of taVNS and subcutaneous triamcinolone acetonide injection at the retroauricular mastoid sieve area. The interventions were administered over a one-month period, with taVNS delivered twice daily. Assessments were performed at three time points: baseline (T0), immediately post-treatment (T1), and one month after treatment completion (T2). The primary outcome was tinnitus severity, measured using the Tinnitus Functional Index (TFI). Secondary outcomes included sleep quality (Insomnia Severity Index, ISI), anxiety (Generalized Anxiety Disorder-7, GAD-7), and depression (Patient Health Questionnaire-9, PHQ-9).

Results

Significant improvements in tinnitus severity were observed, as reflected by a reduction in TFI scores from baseline to T1 (P = 0.002), with sustained improvement at T2 (P = 0.054). ISI scores also showed significant improvement from T0 to T1 (P = 0.033), with further improvement at T2 (P = 0.011). Although GAD-7 and PHQ-9 scores did not show immediate improvement post-treatment, both decreased significantly by T2 compared with baseline (GAD-7: P = 0.001; PHQ-9: P = 0.004), indicating delayed but meaningful reductions in anxiety and depressive symptoms.

Conclusion

The combined application of taVNS and retroauricular glucocorticoid injection yielded significant reductions in tinnitus severity. While additional controlled studies are warranted, these results offer preliminary evidence that this non-invasive approach may represent a promising therapeutic strategy for chronic tinnitus.

Zitieren

APA

Chen, S., Han, Y., Liu, Y., Li, J., Shen, Q., Li, Y., Tian, C., & Liu, Y. (2025). Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus. Head and Neck Diseases Conflux. https://doi.org/10.71321/5nx25d85

Vancouver

Chen S, Han Y, Liu Y, Li J, Shen Q, Li Y, et al. Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus. Head and Neck Diseases Conflux. 2025. doi:10.71321/5nx25d85

BibTeX
@article{Chen2025,
  author = {Chen, Shanwen and Han, Yanxun and Liu, Yuchen and Li, Jiaxin and Shen, Qiling and Li, Yichen and Tian, Chunhui and Liu, Yehai},
  title = {Efficacy of Transcutaneous Auricular Vagus Nerve StimulationCombined with Retroauricular Glucocorticoid Injectionin the Treatment of Chronic Tinnitus},
  journal = {Head and Neck Diseases Conflux},
  year = {2025},
  doi = {10.71321/5nx25d85}
}
Kostenlos starten →